Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tobias Pischon"'
Autor:
Matthias B. Schulze, Berend Isermann, Cornelia Weikert, Krasimira Aleksandrova, Ronald Biemann, Juliane Menzel, Rainer Lehmann, Tobias Pischon, Heiner Boeing, Andreas Fritsche, Clemens Wittenbecher, Romina di Giuseppe
Publikováno v:
Cancer research. 76(13)
Omentin is a novel biomarker shown to exert metabolic, inflammatory, and immune-related properties and thereby could be implicated in the risk of colorectal cancer. So far, the association between omentin and colorectal cancer risk has not been evalu
Autor:
Katharina Nimptsch, Krasimira Aleksandrova, Eugene Jansen, Jürgen Janke, Bas Bueno-de-Mesquita, Kim Overvad, Young-Ae Lee, Antonia Trichopoulou, Konstantinos K. Tsilidis, Heiner Boeing, Tobias Pischon, Timothy J. Key, Elisabete Weiderpass Vainio, Mazda Jenab, Elio Riboli
Publikováno v:
Cancer Research. 74:2200-2200
Background: Fetuin-a, also referred to as α2-Heremans-Schmid glycoprotein (AHSG) is a liver protein that inhibits insulin actions. High circulating fetuin-a concentrations have been associated with insulin resistance and hyperinsulinemia, which pose
Autor:
Veronika Fedirko, H. Bas Bueno-de-Mesquita, Mazda Jenab, Elio Riboli, Anne Tjønneland, Tobias Pischon
Publikováno v:
Cancer Research. 73:4814-4814
Background: Obesity is associated with increased colorectal cancer (CRC) risk, but very little research has been conducted to investigate the association between anthropometric factors and survival after CRC diagnosis. Methods: Therefore, we prospect
Autor:
Aedin Cassidy, Charles S. Fuchs, Eric B. Rimm, Éilis J. O'Reilly, Jennifer Y. Lin, Walter C. Willett, Edward Giovannucci, Katharina Nimptsch, Kana Wu, Xuehong Zhang, Tobias Pischon
Publikováno v:
Cancer Research. 73:4820-4820
Background: Flavonoids inhibit the growth of colon cancer cells in vitro. In a recent randomized controlled trial, the Polyp Prevention Trial, a higher intake of one sub-class, flavonols, was significantly associated with a 76% reduced risk of recurr